J B Chemicals and Pharmaceuticals Ltd banner

J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 2 071.8999 INR 0.98% Market Closed
Market Cap: ₹332.6B

Wall Street
Price Targets

JBCHEPHARM Price Targets Summary
J B Chemicals and Pharmaceuticals Ltd

Wall Street analysts forecast JBCHEPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 2 089.47 INR with a low forecast of 1 769.52 INR and a high forecast of 2 436 INR.

Lowest
Price Target
1 769.52 INR
15% Downside
Average
Price Target
2 089.47 INR
1% Upside
Highest
Price Target
2 436 INR
18% Upside
J B Chemicals and Pharmaceuticals Ltd Competitors:
Price Targets
FCBC
First Community Bankshares Inc
1% Upside
BTDR
Bitdeer Technologies Group
190% Upside
ARQT
Arcutis Biotherapeutics Inc
34% Upside

Revenue
Forecast

13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's revenue is 13%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

10% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
10% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 13 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's operating income is 10%. The projected CAGR for the next 3 years is 19%.

Net Income
Forecast

0% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
0% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 13 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's net income is 0%. The projected CAGR for the next 3 years is 21%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JBCHEPHARM's stock price target?
Price Target
2 089.47 INR

According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 2 089.47 INR with a low forecast of 1 769.52 INR and a high forecast of 2 436 INR.

What is J B Chemicals and Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's revenue is 13%. The projected CAGR for the next 3 years is 12%.

What is J B Chemicals and Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 13 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's operating income is 10%. The projected CAGR for the next 3 years is 19%.

What is J B Chemicals and Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
21%

For the last 13 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's net income is 0%. The projected CAGR for the next 3 years is 21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett